These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11813893)

  • 21. The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age.
    Syrjänen RK; Herva EE; Mäkelä PH; Puhakka HJ; Auranen KJ; Takala AK; Kilpi TM
    Pediatr Infect Dis J; 2006 Nov; 25(11):1032-6. PubMed ID: 17072126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of amoxicillin and cefdinir on nasopharyngeal bacterial flora.
    Brook I; Gober AE
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):785-7. PubMed ID: 16172355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the leading causative pathogens in acute otitis media with tympanic membrane perforation?
    Sonsuwan N; Watcharinyanon P; Sawanyawisuth K
    Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():20-22. PubMed ID: 27729132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical/otologic score before and during treatment of acute otitis media.
    Satran R; Leibovitz E; Raiz S; Piglansky L; Press J; Leiberman A; Dagan R
    Acta Paediatr; 2007 Dec; 96(12):1814-8. PubMed ID: 17953728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
    Arguedas A; Dagan R; Leibovitz E; Hoberman A; Pichichero M; Paris M
    Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship among peripheral leukocyte counts, etiologic agents and clinical manifestations in acute otitis media.
    Polachek A; Greenberg D; Lavi-Givon N; Broides A; Leiberman A; Dagan R; Leibovitz E
    Pediatr Infect Dis J; 2004 May; 23(5):406-13. PubMed ID: 15131462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment and outcome of severe and non-severe acute otitis media.
    Hotomi M; Yamanaka N; Samukawa T; Suzumot M; Sakai A; Shimada J; Ikeda Y; Faden H
    Eur J Pediatr; 2005 Jan; 164(1):3-8. PubMed ID: 15549378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of clinical signs and symptoms with bacterial findings in acute otitis media.
    Palmu AA; Herva E; Savolainen H; Karma P; Mäkelä PH; Kilpi TM
    Clin Infect Dis; 2004 Jan; 38(2):234-42. PubMed ID: 14699456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children.
    Dagan R; Schneider S; Givon-Lavi N; Greenberg D; Leiberman A; Jacobs MR; Leibovitz E
    Pediatr Infect Dis J; 2008 Mar; 27(3):200-6. PubMed ID: 18277926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment.
    McCormick DP; Chonmaitree T; Pittman C; Saeed K; Friedman NR; Uchida T; Baldwin CD
    Pediatrics; 2005 Jun; 115(6):1455-65. PubMed ID: 15930204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in otitis media.
    Pelton SI; Leibovitz E
    Pediatr Infect Dis J; 2009 Oct; 28(10 Suppl):S133-7. PubMed ID: 19918136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasopharyngeal biofilm-producing otopathogens in children with nonsevere recurrent acute otitis media.
    Torretta S; Marchisio P; Drago L; Baggi E; De Vecchi E; Garavello W; Nazzari E; Pignataro L; Esposito S
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):991-6. PubMed ID: 22357644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and preliminary evaluation of a parent-reported outcome instrument for clinical trials in acute otitis media.
    Shaikh N; Hoberman A; Paradise JL; Wald ER; Switze GE; Kurs-Lasky M; Colborn DK; Kearney DH; Zoffel LM
    Pediatr Infect Dis J; 2009 Jan; 28(1):5-8. PubMed ID: 19077917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Otomicroscopic findings and systemic interleukin-6 levels in relation to etiologic agent during experimental acute otitis media.
    Foglé-Ansson M; White P; Hermansson A; Melhus A
    APMIS; 2006 Apr; 114(4):285-91. PubMed ID: 16689828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.
    Casellas JM; Israele V; Marín M; Ishida MT; Heguilen R; Soutric J; Arenoso H; Sibbald A; Stamboulian D
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1225-33. PubMed ID: 16061111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with the presence of drug-resistant bacteria and recurrent acute otitis media in children--a study in a private clinic.
    Kikuta S; Ushio M; Fujimaki Y; Kaga K
    Acta Otolaryngol Suppl; 2007 Dec; (559):5-8. PubMed ID: 18340553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenge of recalcitrant acute otitis media: pathogens, resistance, and treatment strategy.
    Leibovitz E
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S8-S11. PubMed ID: 18049381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of nasopharyngeal culture in identification of pathogen in middle ear fluid in chronic otitis media with effusion.
    Eser OK; Ipci K; Alp S; Akyol U; Unal OF; Hascelik G; Sennaroglu L; Gür D
    Indian J Med Microbiol; 2009; 27(3):237-41. PubMed ID: 19584505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.